- Keywords
- kompletní cytogenetická remise, kompletní morfologická remise,
- MeSH
- Abnormal Karyotype MeSH
- Leukemia, Myeloid, Acute * diagnosis complications mortality therapy MeSH
- Chromosome Aberrations * MeSH
- Cytarabine therapeutic use MeSH
- Adult MeSH
- Remission Induction MeSH
- Middle Aged MeSH
- Humans MeSH
- Survival Rate MeSH
- Mitoxantrone therapeutic use MeSH
- Prognosis MeSH
- Antineoplastic Agents classification therapeutic use MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Stem Cell Transplantation * MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
BACKGROUND: Factor V Leiden (FVL) supposedly carries relatively higher risk of deep vein thrombosis (DVT), compared to the risk of pulmonary embolism (PE). AIM: To prove this paradox in a group of patients with various clinical presentation of venous thromboembolism (VTE). MATERIALS AND METHODS: We retrospectively evaluated clinical pattern of VTE in patients who had been referred to vascular clinic shortly after an acute VTE event. In FVL positive and FVL negative groups we compared the prevalence of isolated symptomatic DVT (proximal or distal) and symptomatic PE with/without DVT, and, moreover, asymptomatic DVT or PE. RESULTS: Of 575 patients (mean age 57 years, 50.1% women), 120 were FVL positive and those had significantly higher prevalence of isolated symptomatic DVT, compared to symptomatic PE with/without DVT. Proximal DVT location was significantly more frequent in FVL carriers. The prevalence of asymptomatic PE did not differ between the two groups. The rate of asymptomatic DVT tended to be higher in FVL negative group. In a multivariate analysis, we confirmed FVL to be positively associated with isolated DVT presentation (odds ratio OR 1.757; 95% confidence interval (CI) 1.148-2.690). On the contrary, increasing age and unprovoked nature of VTE event carried a higher risk of symptomatic PE. CONCLUSIONS: We confirmed FVL to be significantly associated with isolated symptomatic DVT despite higher prevalence of proximal DVT in FVL carriers. The fact of relatively lower risk of PE in FVL positive patients might have clinical implication. However, mechanisms of FVL paradox remain to be elucidated.
- MeSH
- Asymptomatic Diseases epidemiology MeSH
- Point Mutation MeSH
- Genetic Carrier Screening MeSH
- Adult MeSH
- Factor V genetics MeSH
- Blood Coagulation genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Embolism * epidemiology genetics physiopathology MeSH
- Prevalence MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Venous Thrombosis * epidemiology genetics physiopathology MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Geographicals
- Ireland MeSH
AIM: The aim of this paper was to assess the prevalence of concurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) in the patients with superficial vein thrombosis (SVT) of the legs and to find factors significantly and independently associated with coincident DVT/PE. METHODS: In the setting of a tertiary referral hospital, patients with SVT, attending vascular clinic, underwent physical examination, laboratory testing and leg vein ultrasound (in the case of clinically suspected PE also perfusion/ventilation lung scan or/and helical CT pulmonary angiography). In statistical analysis, we used unpaired t-test, non-parametric Wilcoxon rank sum test, stepwise logistic regression and multivariable logistic regression model. RESULTS: We examined 138 patients (age 61.4 ± 13.9 years, 36.2% men), with ST mostly on varicose veins (89.9%). The prevalence of concurrent DVT/PE was 34.1%. Neither the clinical manifestation nor SVT localization differed significantly between the group with isolated SVT and that with coincident DVT/PE. Of all the assessed patients characteristics (age and sex, BMI, history of SVT, DVT or PE, hypercoagulable states, cardiovascular risk factors) only two factors were significantly and independently associated with the presence of concurrent DVT/PE. Log BMI was significantly higher in the patients with isolated SVT. Factor V Leiden (FVL) was proved as an independent risk factor for concomitant DVT/PE with odds ratio 2,531 (95% CI 1,064-6,016). CONCLUSION: The prevalence of concurrent DVT/PE in patients with SVT, referred to hospital vascular clinic was 34.1%. Lower BMI (log BMI, respectively) and the presence of FVL were significantly and independently associated with concurrent DVT/PE. Our results should be further investigated in a larger prospective study.
- MeSH
- Tertiary Care Centers MeSH
- Lower Extremity blood supply MeSH
- Factor V genetics MeSH
- Physical Examination MeSH
- Body Mass Index MeSH
- Middle Aged MeSH
- Humans MeSH
- Logistic Models MeSH
- Multivariate Analysis MeSH
- Obesity diagnosis epidemiology MeSH
- Odds Ratio MeSH
- Pulmonary Embolism diagnosis epidemiology MeSH
- Predictive Value of Tests MeSH
- Prevalence MeSH
- Cross-Sectional Studies MeSH
- Activated Protein C Resistance epidemiology genetics MeSH
- Risk Factors MeSH
- Chi-Square Distribution MeSH
- Aged MeSH
- Tomography, Spiral Computed MeSH
- Ultrasonography, Doppler, Color MeSH
- Venous Thrombosis diagnosis epidemiology MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- MeSH
- Research Support as Topic MeSH
- Hematinics therapeutic use MeSH
- Hyperhomocysteinemia blood MeSH
- Hypolipidemic Agents adverse effects MeSH
- Indoles therapeutic use MeSH
- Folic Acid pharmacology MeSH
- Middle Aged MeSH
- Humans MeSH
- Fatty Acids MeSH
- Prospective Studies MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- MeSH
- Hematinics administration & dosage therapeutic use MeSH
- Blood Coagulation drug effects MeSH
- Folic Acid administration & dosage therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Oxidative Stress radiation effects MeSH
- Coagulation Protein Disorders drug therapy MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Comparative Study MeSH
- MeSH
- Mouth Abnormalities complications therapy MeSH
- Child MeSH
- Hernia complications congenital MeSH
- Humans MeSH
- Pituitary Diseases complications MeSH
- Orthodontics, Corrective methods MeSH
- Bone Diseases, Developmental complications MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
- MeSH
- Cytogenetics MeSH
- Karyotyping MeSH
- Humans MeSH
- Prenatal Diagnosis methods MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH